Here we present a protocol for the construction and use of two types of nanocarrier based on
bacterial membrane materials for cancer vaccine delivery. Cancer vaccines induce tumor …

Non-oral long-acting drug delivery systems (LADDS) encompass a range of technologies for
precisely delivering drug molecules into target tissues either through the systemic circulation …

Cancer vaccines based on resected tumors from patients have gained great interest as an
individualized cancer treatment strategy. However, eliciting a robust therapeutic effect with …

Dendritic cell (DC)-based vaccination for cancer treatment has seen considerable
development over recent decades. However, this field is currently in a state of flux toward …

Gliomas make up virtually 80% of all lethal primary brain tumors and are categorized based
on their cell of origin. Glioblastoma is an astrocytic tumor that has an inferior prognosis …

Purpose: Glioblastoma (GBM) is a heterogeneous malignancy with multiple subpopulations
of cancer cells present within any tumor. We present the results of a phase I clinical trial …

Glioblastoma multiforme (GBM) is the most frequently occurring primary brain tumor and has
a very poor prognosis, with only around 5% of patients surviving for a period of 5 years or …

Introduction Glioblastoma is the most common and malignant primary brain tumour with
median survival of 14.6 months. Personalised medicine aims to improve survival by …

Simple Summary Although multiple meta-analyses on active specific immunotherapy
treatment for glioblastoma multiforme (GBM) have demonstrated a significant prolongation of …

Glioblastoma (GB) is the most common high-grade intracranial malignant tumor with highly
malignant biological behavior and a high recurrence rate. Although anti-PD-1/PD-L1 …